Neoadjuvant Cisplatin/Docetaxel (CDDP/TXT) and Chemoradiation for Head and Neck Cancer

NCT00982436 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Neoplasms

Interventions

DRUG: Docetaxel/cisplatin
RADIATION: Radiotherapy
DRUG: Carboplatin

Sponsor

University of Vermont